Trials / Conditions / Familial Primary Pulmonary Hypertension
Familial Primary Pulmonary Hypertension
6 registered clinical trials studyying Familial Primary Pulmonary Hypertension — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension NCT04908397 | Vanderbilt University Medical Center | Phase 1 |
| Terminated | A Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH NCT04084678 | United Therapeutics | Phase 3 |
| Enrolling By Invitation | A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Exten NCT03683186 | United Therapeutics | Phase 3 |
| Completed | Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension NCT03528902 | Vanderbilt University Medical Center | Phase 2 |
| Completed | A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients NCT03626688 | United Therapeutics | Phase 3 |
| Withdrawn | Efficacy Study of Cardizem in Pulmonary Arterial Hypertension NCT01645826 | University of South Florida | N/A |